GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSFF) » Definitions » Debt-to-EBITDA

OSSFF (Embla Medical hf) Debt-to-EBITDA : 2.76 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Embla Medical hf Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Embla Medical hf's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $52.8 Mil. Embla Medical hf's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $447.0 Mil. Embla Medical hf's annualized EBITDA for the quarter that ended in Dec. 2024 was $181.0 Mil. Embla Medical hf's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 2.76.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Embla Medical hf's Debt-to-EBITDA or its related term are showing as below:

OSSFF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.92   Med: 2.74   Max: 5.55
Current: 3.01

During the past 13 years, the highest Debt-to-EBITDA Ratio of Embla Medical hf was 5.55. The lowest was 0.92. And the median was 2.74.

OSSFF's Debt-to-EBITDA is ranked worse than
71.73% of 428 companies
in the Medical Devices & Instruments industry
Industry Median: 1.395 vs OSSFF: 3.01

Embla Medical hf Debt-to-EBITDA Historical Data

The historical data trend for Embla Medical hf's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Debt-to-EBITDA Chart

Embla Medical hf Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.55 3.03 4.12 3.25 2.94

Embla Medical hf Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.78 4.57 2.92 2.78 2.76

Competitive Comparison of Embla Medical hf's Debt-to-EBITDA

For the Medical Devices subindustry, Embla Medical hf's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Debt-to-EBITDA falls into.



Embla Medical hf Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Embla Medical hf's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(52.756 + 447.033) / 169.784
=2.94

Embla Medical hf's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(52.756 + 447.033) / 180.968
=2.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.


Embla Medical hf  (OTCPK:OSSFF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Embla Medical hf Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.

Embla Medical hf Headlines

From GuruFocus

Q2 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus Research 04-24-2024

Q4 2021 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Embla Medical hf: Interim Report Q3 2024

By PRNewswire 10-22-2024

Q1 2020 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Preliminary Q2 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus News 02-06-2025